New Nestable Cart with Ultralife Power Launches at HIMSS

Innovative cart and power solution to be unveiled at IT healthcare show

Nestable Cart with Ultralife Power

Battery manufacturer Ultralife Corporation will join forces with cart manufacturer Karta to launch a complete medical cart and power solution on booth 1237 (Hall A) at HIMSS, from March 12-14, 2024 at the Orange County Convention Center in Orlando, Florida.

Developed specifically to use Ultralife’s X5 Power System, multiples of the new carts from Karta can be compactly nested together with their power systems attached, to reduce the amount of storage space by 35 per cent. Utilizing the X5’s output of 120VAC 60Hz, these innovative carts can power laptops, all in one systems, and mini PCs. This can be achieved by plugging the power system into AC mains or, when AC mains is not available or convenient, via. two external hot-swappable batteries (276Wh each).

High-Quality Aluminum

Both the cart and power system are built from high-quality aluminum, with Karta also having steel components, to ensure durability and ease-of-sterilization. The batteries can be removed from the power system with a single hand and can be connected in either orientation to ensure fast and smooth operation. The cart itself is equipped with adjustable height settings and high-quality castors for seamless mobility, alongside a range of customizable accessories to fit various clinical workflows.

Eric Lind, Senior Vice President of Sales at Ultralife

“For the past three years, the X5 Power System has proven to be really popular at HIMSS. Therefore, it seemed only natural that we should launch the complete cart and power solution at this year’s event. Visitors to our booth will also be able to discuss the X5-LITE Power Solution for pole/mobile carts that only require USB-C or USB-A power.”

Attendees can also learn more about Ultralife’s other medical power solutions, which include pre-engineered batteries for ventilators, x-ray, and imaging equipment, non-rechargeable cells for remote patient monitoring or asset tracking, as well custom battery design and manufacturing services for specialized needs.

HIMSS 2024 will run from March 12-14 at the Orange County Convention Center in Orlando, Florida. Visitors to the event can book a one-to-one appointment with an Ultralife representative using this form. Alternatively, to find out more information about Karta and the X5 power solutions, contact a member of the team on the Ultralife website.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”